A health worker takes a swab during a rapid antigen test for Covid-19 in Andosilla today.
The international health agency and the Foundation for Innovative New Diagnostics closed a deal with an Indian firm to produce up to 120 million tests this year for low and middle-income countries, to be sold at half the going price of US$5. Less precise but far faster and cheaper than other forms of Covid-19 diagnosis, rapid antigen tests are considered an important weapon in the pandemic battle.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.